| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |